Recommendations for the management of drug–drug interactions between the COVID‐19 antiviral nirmatrelvir/ritonavir (Paxlovid) and comedications
…, L Waters, D Burger, DJ Back, S Khoo - Clinical …, 2022 - Wiley Online Library
The coronavirus disease 2019 (COVID‐19) antiviral nirmatrelvir/ritonavir (Paxlovid) has been
granted authorization or approval in several countries for the treatment of patients with mild …
granted authorization or approval in several countries for the treatment of patients with mild …
Controversies in HIV-associated neurocognitive disorders
…, S Letendre, BD Michael, JC McArthur, S Khoo… - The Lancet …, 2014 - thelancet.com
Cross-sectional studies show that around half of individuals infected with HIV-1 have some
degree of cognitive impairment despite the use of antiretroviral drugs. However, prevalence …
degree of cognitive impairment despite the use of antiretroviral drugs. However, prevalence …
[HTML][HTML] HIV infection and stroke: current perspectives and future directions
HIV infection can result in stroke via several mechanisms, including opportunistic infection,
vasculopathy, cardioembolism, and coagulopathy. However, the occurrence of stroke and …
vasculopathy, cardioembolism, and coagulopathy. However, the occurrence of stroke and …
[HTML][HTML] Clinical features and management of human monkeypox: a retrospective observational study in the UK
…, ER Hunter, M Jacobs, SH Khoo… - The Lancet Infectious …, 2022 - thelancet.com
Background Cases of human monkeypox are rarely seen outside of west and central Africa.
There are few data regarding viral kinetics or the duration of viral shedding and no licensed …
There are few data regarding viral kinetics or the duration of viral shedding and no licensed …
[HTML][HTML] Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label …
…, M Brady, J Fox, S Taylor, S Antonucci, SH Khoo… - The Lancet, 2016 - thelancet.com
Background Randomised placebo-controlled trials have shown that daily oral pre-exposure
prophylaxis (PrEP) with tenofovir–emtricitabine reduces the risk of HIV infection. However, …
prophylaxis (PrEP) with tenofovir–emtricitabine reduces the risk of HIV infection. However, …
[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529
was announced, containing far more mutations in Spike (S) than previously reported …
was announced, containing far more mutations in Spike (S) than previously reported …
[HTML][HTML] Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an …
Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …
British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008.
BG Gazzard - HIV medicine, 2008 - search.ebscohost.com
The article presents guidelines from the British HIV Association for the treatment of HIV-1-infected
adults using antiretroviral therapy. It presents data from clinical trials on the treatment …
adults using antiretroviral therapy. It presents data from clinical trials on the treatment …
[HTML][HTML] Two cases of monkeypox imported to the United Kingdom, September 2018
…, M Jacobs, L Kaindama, P Katwa, S Khoo… - …, 2018 - eurosurveillance.org
In early September 2018, two cases of monkeypox were reported in the United Kingdom (UK),
diagnosed on 7 September in Cornwall (South West England) and 11 September in …
diagnosed on 7 September in Cornwall (South West England) and 11 September in …
Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries
A Hill, S Khoo, J Fortunak, B Simmons… - Clinical Infectious …, 2014 - academic.oup.com
Background. Several combinations of 2 or 3 direct-acting antivirals (DAAs) can cure hepatitis
C virus (HCV) in the majority of treatment-naive patients. DAAs for HCV infection have …
C virus (HCV) in the majority of treatment-naive patients. DAAs for HCV infection have …
